Showing results (1011-1020 of 2,735) with videos related to
Sort By:
Pageof 274
Pharmacogenomics|October 20, 2011
The effect of ABCB1 genetic variants on chemotherapy response in HIV and cancer treatmentKerry Reed, Amadeo M ParissentiPharmacogenomics|September 10, 2011
Impact of genetic polymorphisms in ABCB1, CYP2B6, OPRM1, ANKK1 and DRD2 genes on methadone therapy in Han Chinese patientsChin-Chuan Hung, Mu-Han Chiou, Bo-Hau Huang, et al.Pharmacogenomics|September 10, 2011
Genetic polymorphisms in CYP3A4 are associated with withdrawal symptoms and adverse reactions in methadone maintenance patientsChia-Hui Chen, Sheng-Chang Wang, Hsiao-Hui Tsou, et al.Pharmacogenomics|September 17, 2011
Four decades of modern pharmacogenomics: from promise to clinical utility. World PGX Summit 2011. Boston, USA, 26-27 April, 2011Peter Ma GroenenPharmacogenomics|September 17, 2011
The association of polymorphisms in 5-fluorouracil metabolism genes with outcome in adjuvant treatment of colorectal cancerShoaib Afzal, Milena Gusella, Søren Astrup Jensen, et al.Pharmacogenomics|September 17, 2011
Dihydropyrimidine dehydrogenase gene as a major predictor of severe 5-fluorouracil toxicityUrsula Amstutz, Tanja K Froehlich, Carlo R LargiadèrPharmacogenomics|August 3, 2011
Impact of genetic variants on post-clopidogrel platelet reactivity in patients after elective percutaneous coronary interventionOrsolya Rideg, András Komócsi, Tamás Magyarlaki, et al.Pharmacogenomics|August 3, 2011
Dopamine-related genes and spontaneous smoking cessation in ever-heavy smokersLutz P Breitling, Heiko Müller, Thomas Illig, et al.Pharmacogenomics|December 23, 2011
Association of polymorphisms in EPHX1, UGT2B7, ABCB1, ABCC2, SCN1A and SCN2A genes with carbamazepine therapy optimizationChin-Chuan Hung, Wei-Lun Chang, Jia-Ling Ho, et al.Pharmacogenomics|February 7, 2012
Pharmacogenomics of the heptahelical receptor regulators G-protein-coupled receptor kinases and arrestins: the known and the unknownAnastasios Lymperopoulos, Ashley BathgatePageof 274